search
Dr. Tal Zaks
A man stands outside an entrance to a Moderna, Inc., building, Monday, May 18, 2020, in Cambridge, Mass. Moderna announced Monday that an experimental vaccine against the coronavirus showed encouraging results in very early testing, triggering hoped-for immune responses in eight healthy, middle-aged volunteers.(AP Photo/Bill Sikes)
May 28, 2020, 3:21 am
Amid virus vaccine hopes, Moderna top execs said to have sold millions in stocks
US biotech firm’s shares soared when it claimed progress in trials; analysts say sales, including by Israeli chief medical officer, are legal but undermine faith in company
By TOI staff and Agencies
In this March 16, 2020, file photo, a pharmacist gives Jennifer Haller, left, the first shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. The vaccine by Cambridge, Massachusetts-based Moderna Inc., generated antibodies similar to those seen in people who have recovered from COVID-19 in a study volunteers who were given either a low or medium dose. (AP Photo/Ted S. Warren, File)
May 18, 2020, 9:04 pm
Moderna’s Israeli top medical officer: We’ve shown today that our vaccine works
US biotech firm’s shares soar as it claims tests of first volunteers show its vaccine candidate produces immune response, ‘has potential to prevent COVID-19’; Phase 3 tests in July
By TOI staff and Agencies
Load More
Now, more than ever, is the time to support quality journalism
A message from the Editor
David Horovitz

Our team is covering the coronavirus crisis in Israel and the Jewish world around the clock - because we know how essential trustworthy information is to you right now. If you appreciate the fast, fair and free journalism of Times of Israel, then now is the time to support our work - and receive an AD-FREE experience.

Read more

For as little as $6 a month, you can help support our independent journalism — and enjoy an AD-FREE experience, as well as special content and benefits as a Times of Israel Community member.

The Times of Israel covers one of the most complicated and contentious parts of the world. Determined to keep readers fully informed and enable them to form their own opinions, The Times of Israel has established itself as the leading source of independent and fair-minded journalism on Israel, the region and the Jewish world.

We've achieved this by investing ever-greater resources in our journalism while keeping all of the content on our site free.

Unlike many other news sites, we have not put up a paywall. But we would like to invite readers who can afford to do so, and for whom The Times of Israel has become important, to help support our journalism by joining The Times of Israel Community.

So join now - and for as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE on desktop and mobile, as well as special benefits and status as a Times of Israel Community member.

* The AD-FREE experience is available for signed-in Community members, on The Times of Israel website on desktop and mobile, and in the iOS and Android apps. Minimal advertising will continue to display on The Times of Israel newsletters.

Join the times of israel community Join our community Already a member? Sign in to stop seeing this